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Abstract
Sinus augmentation using rhBMP-2-loaded synthetic bone 
substitute with simultaneous implant placement in rabbits
Myung-Jae Joo, D.D.S., M.S.D
Department of Dentistry
The Graduate School, Yonsei University
(Directed by Professor Ui-Won Jung, D.D.S., M.S.D., PhD.)
Objective: The aim of this study was to determine the effect of recombinant human 
bone morphogenetic protein-2 (rhBMP-2) loaded synthetic bone substitute on 
implants that are simultaneously placed with sinus augmentation in rabbits.
Materials and methods: A circular access window was prepared in the maxillary 
sinus of rabbits (n = 5) for a bone graft around an implant (ø3 x 6 mm) that was 
simultaneously placed anterior to the window. RhBMP-2(0.1mg/ml) loaded synthetic 
bone substitute was placed on one side of the sinus for the experimental group, and 
saline-soaked synthetic bone substitute was placed on the other side of the sinus for 
the control group. After 4 weeks, block sections containing the augmented sinus and 
implants were obtained for analyses by micro computed tomography (CT) and 
histology.
vResults: Osseointegration occurred between the implant and cortical bone, and newly 
formed bone lining the implant surface was observed in both micro CT and light 
microscopy. Volumetric analysis showed that the median amount of newly formed 
bone was significantly greater in the BMP group than the control group (51.6 mm3
and 46.6 mm3, respectively; P = 0.019). In the histometric analysis, the 
osseointegration height was also significantly greater in the BMP group at the medial 
surface of the implant (5.2 mm and 4.3 mm, respectively; P = 0.037).
Conclusion: Within the limitations of the study, the implant simultaneously placed 
with sinus augmentation using rhBMP-2 loaded synthetic bone substitute can be 
successfully osseointegrated even when only a limited bone height is available during 
the early stage of healing.
Keywords: Sinus floor augmentation, dental implants, bone substitute, collagen, 
recombinant human bone morphogenetic protein-2
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substitute with simultaneous implant placement in rabbits
Myung-Jae Joo, D.D.S., M.S.D
Department of Dentistry
The Graduate School, Yonsei University
(Directed by Professor Ui-Won Jung, D.D.S., M.S.D., PhD.)
I. Introduction
A dental implant can be either simultaneously placed (in a one-stage
procedure) or placed at the second stage when the atrophic posterior maxilla is to be 
augmented by sinus floor elevation.1,2 If primary stability of the implant is achievable, 
the one-stage technique might be preferred for shortening the overall treatment period 
and skipping the second operation to place the implant.3,4 A randomized controlled 
clinical study found that the survival rate and peri-implant bone-level changes at 
1 year after loading did not differ significantly between implants placed using one-
and two-stage sinus graft procedures.5
2While there are obvious advantages when using one-stage surgery, it might 
be very difficult to achieve primary stability of implants with this approach when 
there is a minimal bone height (< 3 mm) with poor bone quality in the posterior 
maxilla. In some cases the implants could be displaced into the maxillary sinus, 
causing maxillary sinusitis.6 However, improvements in surgical techniques as well as 
in technologies such as the characteristics of the implant surface, thread design and 
surgical devices make it easier for clinicians to achieve initial stability of the 
implant.7 Also, the development of bone substitute to promote bone regeneration and 
osseointegration provides a more predictable procedure along with allowing the 
extended application of the one-stage approach.8 Furthermore, many attempts have 
been made using growth factors (e.g., bone morphogenetic protein), which are known 
to induce rapid bone formation in the maxillary sinus.9
Bone morphogenetic proteins require a carrier material that serves as a 
scaffold for cellular growth and attachment.10 There have been many reports on the 
osteopromotive effects of different carriers, with collagenated biphasic calcium 
phosphate (CBCP) having been used recently as a carrier material in a sinus 
augmentation model showing excellent osteoconductive properties.11,12 Brodie et al13
reported that CBCP increased the proliferation and survival rate of osteoblasts. Our 
previous quantitative and qualitative analyses using micro computed tomography 
(CT) and histology found that CBCP could be an appropriate carrier system.14
Several previous studies have focused on the augmented area without 
implant placement in a rabbit sinus model15-17, with sinus augmentation with 
3simultaneous implant placement in a rabbit sinus model rarely being studied.18 We 
considered it important to determine whether implant osseointegration is achieved 
with and without recombinant human bone morphogenetic protein-2 (rhBMP-2)
loading during the early stage of healing. The aim of this study was therefore to 
determine the effect of rhBMP-2-loaded CBCP on simultaneous implant placement 
with sinus augmentation in rabbits. 
4II. Materials and methods
Experimental Animals
Five male New Zealand white rabbits weighing between 2.5 kg and 3.0 kg 
were selected as the experimental model. The number of animals was determined 
from newly formed bone volume data of our previous study14 and required to have 
95% chance of detecting, as significant at the 5% level. Animals were kept in separate 
cages under standard laboratory conditions with ad libitum access to a diet of standard 
laboratory pellets and water. Animal selection and care, the preparation procedures, 
and the surgical protocols were certified by the Institutional Animal Care and Use 
Committee, Yonsei Medical Center, Seoul, Korea (approval no. 2011-0262).
Experimental Materials
Experimental implants
The acid-etched and sandblasted rough-surface implants used in the study 
(Dentium, Seoul, Korea) had a cylindrical shape with dimensions of ø3 ´ 6 mm 
(Figure 1A). 
5Preparation of rhBMP-2 and assessment of bioactivity 
RhBMP-2 supplied by the Genoss Institute (Suwon, Korea) was extracted 
from inclusion bodies at room temperature, refolded and concentrated. The protein 
was ultimately purified by heparin-affinity chromatography, filtered and then freeze-
dried. Mouse bone-marrow stromal cells and fetal bovine serum were incubated. 
RhBMP-2 was added at various concentrations to 1 ml of fresh medium after 
removing the supernatant. RhBMP-2 activity was determined using the Alkaline 
Phosphatase Assay Kit (BioVision, Milpitas, CA, USA) after further cultivation. The 
absorbance at 405 nm was recorded after 20 min of incubation at 37°C. The activity 
was related to the protein content in each sample using a BCA protein assay (Pierce, 
Rockford, IL, USA).
Preparation of rhBMP-2-loaded CBCP
CBCP (Osteon Collagen, Genoss Institute) with a particle size of 0.3–0.5 
mm was used as the carrier of rhBMP-2 in this study. This carrier was a cylindrical 
shaped bone filler (ø6.0 ´ 5.0 mm) composed of synthetic bone (70% hydroxyapatite, 
30% β-tricalcium phosphate and a natural type I collagen). RhBMP-2 (0.1 mg/ml) 
was diluted in a buffer, and 0.2 ml of this rhBMP-2 solution was loaded onto particles 
of CBCP for the experimental (BMP) group, while CBCP was soaked in saline only 
for the control group.
6Experimental Design
Two groups were allocated into both sinuses of rabbit, respectively. In each 
animal, CBCP soaked with saline was placed on one side of the maxillary sinus for 
the control group, while CBCP loaded with rhBMP-2 was inserted on the other side 
for the BMP group. The BMP and control groups were placed at random. After bone 
grafting, two implants were placed at 3 mm anterior to the holes in the left and right 
lateral walls, respectively. The sample size per group was five.    
Surgical Procedures
All surgeries were performed under general anesthesia with additional 
infiltration anesthesia being applied to the nasal dorsum. Protocols reported by Kim et 
al14 were used to prepare the access window and elevate the sinus membrane (SM). 
After the nasal dorsum of each rabbit was shaved, the surgical field was disinfected 
with iodine solution. The dorsal surface of the nasal bone was exposed by making a 
midline incision on the skin and periosteum. A trephine bur (C-reamer, Neobiotech, 
Seoul, Korea) was used to form two circular holes with diameters of 5.5 mm on the 
two sides of the nasal bone. The SM was elevated to the hole approximately 10 mm 
anteriorly. While protecting the SM using a surgical curette, the implant sites were 
drilled to a diameter of 3 mm in front of the holes using a pilot drill followed by a 
7final drill (2.7 mm in diameter). CBCP with rhBMP-2 or saline was packed into the 
hole anteriorly towards the implant site before inserting the implants. Two implants 
were inserted manually into the cortical bone until they were seated up to their 
shoulder (Figure 1B). The holes were covered with periosteum. The skin and 
periosteum were sutured with glyconate absorbable monofilament (4-0 Monosyn, B-
Braun, Aesculap, PA, USA). At 4 weeks after surgery, the rabbits were sacrificed 
using an overdose of anesthesic.
Radiographic Analysis
Including the implant and surrounding tissues, all specimens were fixed in 
10% formalin for 10 days, and then images were obtained using a high-resolution 
micro CT system (SkyScan 1173, SkyScan, Aartselaar, Belgium) at a resolution of 
35 μm (achieved using 100 kV and 100 μA). The specimens were analyzed for the 
remaining bone substitute material and newly formed bone according to 8-bit 
greyscale values from 100 to 255 and from 70 to 100, respectively. The On-Demand 
three-dimensional (3D) software (Cybermed, Seoul, Korea) was utilized to obtain 3D 
images for making volume measurements of the overall augmented region, newly 
formed bone, implant and remaining particles of graft materials within the entire 
region of interest.
8Histologic and Histomorphometric Analyses
The fixed specimens were dehydrated in ethanol, embedded in methacrylate 
and sectioned in the centre of the augmented sinus at the sagittal plane using a 
diamond saw (Exakt, Apparatebau, Norderstedt, Germany). The final thickness of the 
reduced central section was about 20 μm. Each section was stained with hematoxylin-
eosin. The histological slides were observed and captured digitally under a light 
microscope (BX50, Olympus, Tokyo, Japan). 
Histomorphometric measurements were made with the aid of an automated 
image-analysis system (ImagePro Plus, Media Cybernetics, Silver Spring, MD, USA). 
Linear measurements including the augmented height (AH) and protruding height 
(PH) into the sinus pouch of the implant were made on each section. The cortical 
bone height (CBH) and the distance from the basal cortical bone to the highest point 
of osseointegration (OH) were measured on both the medial and lateral sides of the 
implant (Figure 2). Characteristics of the total augmented area such as the areas of 
newly formed bone, residual materials, non-mineralized tissue and implant were 
separately and manually traced and calculated. The ratios of the total length of bone 
contact to the implant thread length (also known as BIC) in the section were also 
obtained.
9Statistical Analysis
The statistical analysis was performed using the R statistical software 
(version 3.2.2, http://www.r-project.org). The non-parametric mixed model was used 
for comparing radiographic and histomorphometric parameters between two groups.19
The cut-off for statistical significance was set at P < 0.05. Bonferroni correction was 
used for multiple comparisons.
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III. Results
Clinical Findings
During the surgical procedure, rigid fixation was achieved for all implants 
by manual insertion into the cortical bone. The sinus augmentation surgery with 
simultaneous implant placement was performed without any significant problems 
such as SM perforation in all of the experimental animals. All of the animals survived 
until the planned time and their wounds healed without any specific events.
Radiographic Analysis : micro CT
At 4 weeks there were no instances of perforation in the augmented pouches 
in the BMP and control groups, and they were filled evenly with the remaining bone 
substitute and newly formed bone in both coronal and sagittal micro CT sectional 
views. In both groups the inserted part of the implant was thoroughly enveloped by 
newly formed bone and bone substitutes in cross-sectional views (Figure 3). The 
amount of newly formed bone on the apex of the implant was greater in the BMP 
group than the control group. The remaining bone substitute was distributed more 
laterally than medially in sagittal views and more anteriorly than posteriorly in 
11
coronal views in both groups. The median augmented volume was significantly 
greater in the BMP group than the control group (153.5 mm3 and 116.1 mm3, 
respectively; P = 0.034), as was the median newly formed bone volume (51.6 mm3
and 46.6 mm3, P = 0.019; Table 1). 
Histologic and Histomorphometric Analyses
The maxillary sinus pouch was enveloped by a thin cortical layer and 
respiratory mucosa. The SM was intact, and there were no signs of inflammation. 
Osseointegration of the implant was evident throughout the cortical bone area in all 
specimens. The newly formed bone appeared to form from the cortical bone towards 
the implant apex along the implant surface and around the residual bone substitute. 
Newly formed bone was observed evenly in the hole to the SM in the BMP group, but 
mainly in the hole to middle parts of the augmented pouch in the control group 
(Figure 4). The contact between newly formed bone and implant medial surface was 
positioned more apically in the BMP group. The trabecular pattern of bone formation 
did not show any significant histological differences between the BMP and control 
groups. The intertrabecular space was filled with fibrovascular tissue and bone 
marrow in both groups (Figure 5). 
The linear measurements performed in the histomorphometric analysis 
revealed that the median CBH was 0.50 mm in both the BMP and control groups. The 
12
AH of the maxillary sinus pouch was significantly greater in the BMP group than the 
control group (6.4 mm and 6.0 mm, respectively; P = 0.004). The OH was 
significantly greater in the BMP group than the control group at the medial surface of 
the implant (5.2 mm and 4.3 mm, respectively; P = 0.037), but it did not differ 
significantly at the lateral surface of the implant (5.3 mm and 4.6 mm, P = 0.123;
Table 2).
None of the measured areas differed significantly between the BMP and 
control groups (P > 0.05, Table 3); this was also the case for BIC (25.3% and 24.7%, 
respectively; P > 0.05).
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IV. Discussion
The present study evaluated the effect of rhBMP-2-loaded CBCP on bone 
formation of sinus augmentation with simultaneous implant placement in rabbits. In 
the surgical phase, rigid fixation of the implants was achieved in rabbit sinuses with a
median CBH of 0.5 mm. At 4 weeks after the surgery, augmented bone substitute and 
implants were localized in sinus pouches without any complications, and newly 
formed bone had formed from cortical bone to the apical portion of the implants. The 
augmented volume, newly formed bone volume, AH and OH were greater in the 
BMP than the control group, but there was no intergroup difference in BIC. These 
results support that the use of rhBMP-2-loaded CBCP allows successful implantation 
with sinus augmentation even when only a minimal bone height is available during 
the early stage of healing.
The previous study was performed to graft 0.1 mg/ml rhBMP-2-loaded 
CBCP into rabbit sinus, and significantly larger volumes of augmented and newly 
formed bone were founded in the experimental group than the control group 4 weeks 
later.14 It was speculated that postoperative swelling induced by rhBMP-2 would 
result in a larger initial augmented volume, which could subsequently be replaced by 
accelerated bone formation. Such early corticalization of the SM surrounding area can 
resist the positive respiratory pressure and thereby reduce volumetric shrinkage. As a 
further series, the present study performed simultaneous implant placement with sinus 
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augmentation. Despite the same rhBMP-2 concentration and dosage being applied in 
the present study, the differences in volume appeared to be smaller than in the 
previous study. This was attributed to the effects of rhBMP-2 not only on early 
corticalization of the SM but also on new bone formation in the peri-implant area. 
Several studies have found that rhBMP-2 contributes to new bone formation around 
the implant, thereby supporting this role of rhBMP-2.20-22 Therefore, a higher 
concentration and dosage of rhBMP-2 might be needed in order to achieve results 
similar to those in the previous study. 
The early stability of the implant is determined by the peri-implant bone 
quantity and maturity23, which could be predictive of the long-term prognosis of the 
implant. When an implant is placed, the new bone formation appears to start from the 
original cortical bone of the sinus wall and progress towards the center in the apical 
direction.9 Newly formed cortical bone could play a similar role to the original 
cortical bone. In the present study, the OH-to-PH ratios were 103.5% and 97.3% 
medially and laterally, respectively, in the BMP group, and 83.7% and 89.3% in the 
control group. This indicates that almost the entire height of implant was covered by 
newly formed bone in the BMP group. RhBMP-2 was effective in bone formation on 
the medial surface of the implant, which was closer to the axial wall24, resulting in 
rhBMP-2 stimulating angiogenesis through the chemotaxis of endothelial cells and 
osteoblasts that exist in cortical bone and around the SM.25 It is therefore suggested 
that rhBMP-2 accelerates peri-implant bone formation and thereby enhances the early 
stability of the implant. 
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Comparing with the BIC values of Kim et al18 (11.3% for blood clots, 23.0% 
for autogenous bone and 29.0% for bovine-derived hydroxyapatite), BIC of CBCP 
grafting was similar to autogenous bone grafting regardless of whether or not rhBMP-
2 was used (25.3% for BMP and 24.6% for control). It seems that rhBMP-2 itself was 
not effective in directing newly formed bone to contact the implant surface. Wikesjo 
et al20 found no significant difference in BIC when rhBMP-2 and absorbable collagen 
sponge were applied to supra-alveolar defects of mongrel dogs for 8 weeks. However, 
a histological analysis revealed that rhBMP-2 affected new bone formation more 
widely on the implant surface. A wider area of newly formed bone means that more 
of the implant surface will be covered, which can increase the implant stability. 
Fixation at the cortical bone is always important for initial stability of an implant.26
However, one of the main disadvantages of one-stage implantation is the possibility 
of fixation failure leading to displacement of the fixture into the maxillary sinus. In 
the present study model, the implant was fixed to thin cortical bone (less than 0.5 mm 
thick, representing less than 10% of the fixture length) by manipulation and 
modification of the implant design such as the inclusion of a crestal shoulder and 
microthreading in the cortical contact area. Also, adding rhBMP-2 to CBCP can 
achieve secondary stability via new bone formation around the implant surface, as 
discussed above. 
The volume but not the area differed significantly between the two study 
groups. This could have been due to the smallness of the sample and variations in the 
areas selected for analysis. The limitations of the present study include the smallness 
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of the sample and performing measurements at a single point in time. Therefore, 
future studies should include larger samples and obtain results at various time points. 
Although the rabbit sinus model has a strong osteogenic potential for observing the 
effects of rhBMP-2 on a sinus graft after 4 weeks, the bone contact around the 
implant should also be observed during the later stage of healing; that is, after more 
than 4 weeks.
In conclusion, an implant simultaneously placed with sinus augmentation 
using rhBMP-2-loaded synthetic bone substitute can be successfully osseointegrated 
even when there is a limited height of bone available during the early stage of healing, 
thereby achieving a reduced healing time when cortical fixation is obtained.
17
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Figure Legends
Figure 1. (A) Photograph of the implant used in this study. (B) Two implant sites 
and holes were prepared bilaterally. Venous-blood-filled parts of the sinus after 
placing the implants. (Ant, anterior; Post, posterior).
Figure 2. Schematic showing the measured parameters. (Med, medial; Lat, lateral; 
CBH, cortical bone height; AH, augmented height; PH, protruding height; OH, 
distance from the basal cortical bone to the highest point of osseointegration).
Figure 3. Radiographic findings in micro computed tomography. False-color 
representation of radiographic findings in a cross-sectional view. Note that the 
augmented bone substitutes (green) are well maintained within the maxillary sinus, 
and that the implants are thoroughly enveloped by newly formed bone (purple) and 
augmented bone substitutes. (A and B) BMP group; (C and D) Control group. (A and 
C) are coronal views, while (B and D) are sagittal views.
Figure 4. Histological photomicrographs of the total augmented area after 4 weeks 
of healing. (A) BMP group. (B) Control group. The osseointegration of the implant 
was evident throughout the cortical bone area in both groups. (CB, cortical bone; RBS, 
residual bone substitute; hematoxylin-eosin [H&E], the scale bar = 1 mm).
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Figure 5. Histological photomicrographs of the apical area after 4 weeks of healing. 
(A) BMP group. (B) Control group. More new bone formed around the apex of the 
implant in the BMP group than the control group. (SM, sinus membrane; NB, newly 
formed bone; H&E, the scale bar = 500 μm).
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Tables
Table 1. Volumetric measurements from micro-CT data (Median [min, max]; mm3)
NB RBS Implant Augmented Total
BMP
51.6 a
[43.9, 59.2]
30.0
[27.4, 37.4]
95.7
[93.4, 101.7]
153.5 b
[98.9, 181.3]
249.2
[200.7, 276.5]
Control
46.6
[34.5, 48.7]
33.4
[28.2, 37.1]
101.5
[97.8, 102.5]
116.1
[104.6, 121.1]
218.6
[208.0, 249.8]
P-value 0.019 0.476 0.127 0.034 0.095
Note : NB, newly formed bone; RBS, remaining bone substitute. 
a, b Significantly greater than control group (P < 0.05)
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Table 2. The histomorphometric linear measurements in the augmented pouch 
(Median [min, max]; mm)
AH PH CBH OH
Medial Lateral Medial Lateral
BMP
6.4 a
[6.1, 6.4]
5.2
[5.0, 5.4]
0.5
[0.4, 0.6]
0.5
[0.3, 0.6]
5.2 b
[4.3, 5.7]
5.3
[4.7, 5.4]
Control
6.0
[5.5, 6.3]
5.4
[5.1, 5.4]
0.5
[0.4, 0.6]
0.5
[0.4, 0.6]
4.3
[3.7, 5.1]
4.6
[4.3, 4.9]
P-value 0.004 0.908 0.804 0.285 0.037 0.123
Note: AH, augmented height; PH, protruding height; CBH, cortical bone height; OH,
the most highest osseointegrated point to cortical bone base length. 
a Significantly greater than control group (P < 0.01)
b Significantly greater than control group on medial surface (P < 0.05)
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Table 3. The histomorphometric area measurements in the augmented pouch (Median 
[min, max]; mm2)
NB RBS Soft tissue Implant Total
BMP
2.0
[1.2, 3.5]
4.4
[0.6, 4.8]
10.9
[10.3, 12.1]
13.4
[10.4, 14.1]
30.2
[25.5, 34.5]
Control
1.9
[0.9, 2.9]
3.0
[2.7, 5.8]
10.5
[7.0. 12.4]
13.6
[13.4, 13.8]
29.8
[26.4, 32.6]
P-value 0.794 0.908 0.598 0.270 0.587
Note: NB, newly formed bone; RBS, remaining bone substitute. 
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국문요약
토끼에서 rhBMP-2 동반하여 합성골 적용한
상악동 증대술과 임플란트 동시식립
<지도교수 정 의 원>
연세대학교 대학원 치의학과
주 명 재
임플란트 식립에 있어 상악 후방 무치악 부위는 상악동의 함기화, 
치조골의 흡수 등으로 인하여 수직적인 공간의 부족을 흔하게 보인다. 
수직적인 공간을 확보하기 위하여 임플란트 식립 전 상악동 증대술을 주로
시행하며 대개 식립 전까지 4 개월 이상의 치료기간이 추가로 필요하다. 
추가로 필요한 기간을 단축하기 위하여 상악동 증대술과 동시에
임플란트를 식립하는 방법이 있으며 동시 식립 후 안정적인 초기치유가
중요하다. 본 연구는 토끼 상악동에 임플란트 식립 시 골형성유도단백질-2 
(rhBMP-2)가 적용된 collagenated biphasic calcium phosphate (CBCP)를
골이식재로 사용한 상악동 증대술을 동시에 시행함으로써 초기
치유기간에서 rhBMP-2 의 효과를 확인해보기 위하여 계획되었다.
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총 5 마리의 토끼을 대상으로 상악동 양측에 골이식을 위한 창을
형성하고 전방으로 임플란트(ø3 x 6 mm)를 수조작을 통해 고정을 확인하며
식립하였다. 상악동 좌우로 실험군에는 rhBMP-2 가 적용된 CBCP 를, 
대조군에는 생리식염수가 적용된 CBCP 를 각각 이식하였다. 4 주 후, 
방사선학적으로 2 차원적인 단면영상과 3 차원적인 재건영상을 통해 증대된
부피, 신생골의 부피 등을 분석하고, 조직계측학적으로는 선형분석으로
피질골의 두께, 골-임플란트 접촉, 임플란트 플랫폼으로부터 신생골 형성
근단부까지의 거리(내측 및 외측), 임플란트 플랫폼으로부터 증대된 상악동
경계까지의 거리를 측정하였으며, 면적분석으로 신생골양, 잔존 골대체제양, 
광화조직양, 섬유혈관조직양을 분석하였다.
방사선 및 조직학적 관찰에서 양쪽 군 모두 임플란트와 피질골과의
골유착이 이루어졌으며 임플란트 근단부를 향하여 신생골이 선상으로
형성되는 것을 확인 할 수 있었다. 부피 분석에서 실험군(51.6 mm3)이
대조군(46.6 mm3)보다 신생골 형성이 더 많았다. 골-임플란트 접촉은
통계학적으로 유의한 차이가 나지 않았으나 임플란트 플랫폼으로부터
신생골 형성 근단부까지의 거리는 내측에서 실험군(5.2 mm)이 대조군(4.3 
mm)보다 통계적으로 유의하게 크게 나타났다. 
이상의 연구를 통해, 상악 후방 무치악에서 수직적 공간이 부족한
부위의 rhBMP-2 적용 합성골의 상악동 거상술과 동시에 임플란트 식립을
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시행하는 것은 초기 회복 시기에서 성공적인 골유착을 가능하게 함을
확인할 수 있었다. 
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